Clinical Handbook of Psychotropic Drugs

The classic reference for psychotropic medications

The Clinical Handbook of Psychotropic Drugs and the Clinical Handbook of Psychotropic Drugs for Children and Adolescents are independent and unbiased practical tools for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals. They are packed with unique comparison charts that support effective medication decisions. Color-coding and instantly recognizable icons enable quick access to succinct, bulleted information on all classes of medication, their on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in special populations, nursing implications, and much more. Sections on Natural Health Products, Unapproved Treatments, ECT, BLT, and rTMS are included. Patient and caregiver information sheets are provided as printable PDF files

    • Clinical Handbook of Psychotropic Drugs - new edition
    • Watch our product video on youtube
    • CHPD for Children and Adolescents
    • Online versions
    • Free trial access
    • Order information

    New edition released May 2025

    26th ed. 2025 edited by Ric M. Procyshyn, Katelyn Halpape, David D. Kim
    The classic reference to psychotropic medications for psychiatrists, psychologists, physicians, pharmacists, and nurses, packed with the latest drugs, completely revised sections, and much more.
    Learn more

    New in this edition:

    • Antidepressants chapter revised extensively and includes new sections on the selective serotonin-5-HT1A agonist gepirone and difficult-to-treat depression
    • Antipsychotics chapter includes a new section on the muscarinic agonist/antagonist combination (Xanomeline/trospium chloride), a novel treatment that does not block D2 dopamine receptors. Major revisions to TGA Dosing and Pharmacokinetics
    • Drugs for Treatment of Dementia chapter includes donanemab infusion
    • Drugs for ADHD comparison table expanded
    • Drugs of Abuse chapter has been revised extensively and includes a new section on Psychedelics and Dissociative Drugs
    • New formulations and trade names include: Abilify Asimtufii (aripiprazole extended-release 2-monthly injection), Azstarys (serdexmethylphenidate/dexmethylphenidate capsules), CAMCEVI (leuprolide 6-month slow-release SC depot injection), Drizalma Sprinkle (duloxetine capsules), Eldepryl (selegiline tablets and capsules), Eprontia (topiramate oral solution), Exxua (gepirone extended-release tablets), Ketalar (ketamine hydrochloride injection), Kisunla (donanemab infusion), Lybalvi (olanzapine/samidorphan tablets), Onyda (clonidine extended-release suspension), Relexii (methylphenidate extended-release tablets), Secuado (asenapine transdermal patch), Zurzuvae (zuranolone capsules)

    Clinical Handbook for Children and Adolescents

    5th ed. 2023 edited by Dean Elbe, Tyler R. Black, Ian R. McGrane, Sabina Choi
    The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choices about psychotropic medications for younger patients.
    Learn more

    New in this edition:

    • New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents
    • Neuroscience-based nomenclature added to Product Availability tables
    • Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) chapter completely revised, plus new section on monitoring scales for EPSE
    • Anxiolytics section on buspirone and benzodiazepine comparison table revised
    • Mood Stabilizers chapter extensively revised
    • Natural Health Products comprehensively revised
    • New Unapproved Treatments revised, including preliminary evidence for cannabidiol and folinic acid for autism spectrum disorder and ketamine for mood disorder
    • New agents: deutetrabenazine, ethopropazine, lemborexant, lumateperone, orphenadrine, tetrabenazine, valbenazine, viloxazine
    • New formulations and trade names: Austedo, Caplyta, Dayvigo, Drizalma Sprinkle, Elepsia XR, Eprontia, Evekeo ODT, Gocovri, Hetlioz LQ, Ingrezza, Invega Hafyera, Jornay PM, Loreev XR, Lybalvi, Osmolex ER, Oxtellar XR, Parsitan, Perseris, Qelbree, Qudexy XR, Secuado, Spritam, Tyrvaya, Valtoco

    Also available as online versions

    Clinical Handbook of Psychotropic Drugs for Children and Adolescents Online edited by Dean Elbe, Tyler R. Black, Ian R. McGrane, Sabina Choi
    Learn more
    Clinical Handbook of Psychotropic Drugs Online edited by Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, David D. Kim
    Learn more

    In addition to the spiral-bound print editions, the CHPD and the CHPD for Children and Adolescents are also available as online versions with added features that allow even quicker access to the wealth of information provided:

    • Drug monographs
    • Drug comparisons
    • Responsive design
    • Full-text search
    • Auto-completion powered search function
    • Browse features for generic names, trade names, indication, and interacting agents
    • Hundreds of additional references
    • Literature hot links for quick access to further reading

    Access is available by subscription. For individual customers, subscriptions are available on a 2-year rolling basis. Access details will be e-mailed once your order has been processed (usually within minutes). If you are interested in access for institutions, please contact us via e-mail with your particular requirements. If you prefer not to subscribe online, or for any order enquiries, please contact us.

      Free trial access

      Get free trial access to CHPD Online and CHPD for Children & Adolescents Online for 14 days. Your trial access to each publication will be valid for 14 days from the time you redeem the code. Click here to see how it works.

      If you have any questions or concerns, please don’t hesitate to contact our CHPD Online support.

      Order information

      Do you want print and online? Deal with adults and children? Combine CHPD publications and save. The Clinical Handbook of Psychotropic Drugs is available as a print edition and as an online version, for adults and for children and adolescents. Each print edition and each online subscription (2 years) costs $99.80. (This offer does not apply to the eBooks of the Clinical Handbook.)

      • Buy any two CHPD products and save 25%, or nearly $50.
      • Buy all four CHPD products and get 33% discount off the combined list prices.

      The discount will be applied automatically at checkout.


      Institutional customers, please contact chpd-online@hogrefe.com for subscription information.

      Hogrefe Publishing Corporation

      Contact
      Address

      44 Merrimac St.

      Newburyport,  MA   01950